GAIN A COMPREHENSIVE UNDERSTANDING OF AAV IMMUNOGENICITY ASPECTS
Gain access to the on-demand version of our webcast presented by Nature Research Custom Media to learn:
- Important aspects of AAV efficacy and potency
- The significance, potential impact, and evaluation methods of the pre-existing humoral immune response to AAV vectors
- Current challenges and approaches for the innate immune response in relation to AAV
SPEAKERs:
- Dr. Nageswara Rao Kollu, Senior Director, Apellis
- Dr. Boris Gorovits, VP of non-clinical and
clinical bioanalysis, Regeneron
- Dr. Abraham Scaria, Chief Scientific Officer, Beacon Therapeutics